U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C27H51N8O3P
Molecular Weight 566.7194
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BURIXAFOR

SMILES

NC1=NC(NC[C@H]2CC[C@H](CNCCCNC3CCCCC3)CC2)=NC(=C1)N4CCN(CCP(O)(O)=O)CC4

InChI

InChIKey=QLVSJMZJSABWRX-YHBQERECSA-N
InChI=1S/C27H51N8O3P/c28-25-19-26(35-15-13-34(14-16-35)17-18-39(36,37)38)33-27(32-25)31-21-23-9-7-22(8-10-23)20-29-11-4-12-30-24-5-2-1-3-6-24/h19,22-24,29-30H,1-18,20-21H2,(H2,36,37,38)(H3,28,31,32,33)/t22-,23-

HIDE SMILES / InChI

Molecular Formula C27H51N8O3P
Molecular Weight 566.7194
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Burixafor is an orally bioavailable inhibitor of CXC chemokine receptor 4 (CXCR4) with receptor binding and hematopoietic stem cell-mobilization activities. Burixafor binds to the chemokine receptor CXCR4, thereby preventing the binding of stromal derived factor-1 (SDF-1 or CXCL12) to the CXCR4 receptor and subsequent receptor activation; this may induce the mobilization of hematopoietic stem and progenitor cells from the bone marrow into the blood. CXC motif chemokine receptor 4 (CXCR4) blockade is pursued as an alternative to mesenchymal stem cell treatment after heart transplantation. The augmentation of conventional mycophenolate mofetil plus corticosteroids with a CXCR4 antagonist is potentially effective in improving outcomes after heart transplantation in humans

Approval Year

PubMed

PubMed

TitleDatePubMed
CXCR4 Antagonist Reduced the Incidence of Acute Rejection and Controlled Cardiac Allograft Vasculopathy in a Swine Heart Transplant Model Receiving a Mycophenolate-based Immunosuppressive Regimen.
2018 Dec
Patents
Substance Class Chemical
Created
by admin
on Fri Dec 15 19:17:54 GMT 2023
Edited
by admin
on Fri Dec 15 19:17:54 GMT 2023
Record UNII
2G17Y0Q20G
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BURIXAFOR
INN  
INN  
Official Name English
PHOSPHONIC ACID, P-(2-(4-(6-AMINO-2-(((TRANS-4-(((3-(CYCLOHEXYLAMINO)PROPYL)AMINO)METHYL)CYCLOHEXYL)METHYL)AMINO)-4-PYRIMIDINYL)-1-PIPERAZINYL)ETHYL)-
Common Name English
Burixafor [WHO-DD]
Common Name English
(2-(4-(6-AMINO-2-((((1R,4R)-4-(((3-(CYCLOHEXYLAMINO)PROPYL)AMINO)METHYL)CYCLOHEXYL)METHYL)AMINO)PYRIMIDIN-4-YL)PIPERAZIN-1-YL)ETHYL)PHOSPHONIC ACID
Common Name English
burixafor [INN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C107589
Created by admin on Fri Dec 15 19:17:54 GMT 2023 , Edited by admin on Fri Dec 15 19:17:54 GMT 2023
Code System Code Type Description
PUBCHEM
44479007
Created by admin on Fri Dec 15 19:17:54 GMT 2023 , Edited by admin on Fri Dec 15 19:17:54 GMT 2023
PRIMARY
SMS_ID
300000034120
Created by admin on Fri Dec 15 19:17:54 GMT 2023 , Edited by admin on Fri Dec 15 19:17:54 GMT 2023
PRIMARY
FDA UNII
2G17Y0Q20G
Created by admin on Fri Dec 15 19:17:54 GMT 2023 , Edited by admin on Fri Dec 15 19:17:54 GMT 2023
PRIMARY
INN
9347
Created by admin on Fri Dec 15 19:17:54 GMT 2023 , Edited by admin on Fri Dec 15 19:17:54 GMT 2023
PRIMARY
NCI_THESAURUS
C88323
Created by admin on Fri Dec 15 19:17:54 GMT 2023 , Edited by admin on Fri Dec 15 19:17:54 GMT 2023
PRIMARY
ChEMBL
CHEMBL3545224
Created by admin on Fri Dec 15 19:17:54 GMT 2023 , Edited by admin on Fri Dec 15 19:17:54 GMT 2023
PRIMARY
CAS
1191448-17-5
Created by admin on Fri Dec 15 19:17:54 GMT 2023 , Edited by admin on Fri Dec 15 19:17:54 GMT 2023
PRIMARY
DRUG BANK
DB11970
Created by admin on Fri Dec 15 19:17:54 GMT 2023 , Edited by admin on Fri Dec 15 19:17:54 GMT 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
TARGET -> INHIBITOR
Related Record Type Details
ACTIVE MOIETY